← Back

Shanghai Haixin Group Co Ltd A

600851.CGCNY
7.82+18.5%1Y · CNY

Shanghai Haixin Group Co., Ltd. manufactures and sells pharmaceutical products in China and internationally. It also leases industrial park properties, engages in financial investment and commodity trading, and produces and sells chemical drugs through its sales platform or local distributors. In addition, the company researches, develops, produces, and sells plush fabrics and clothing, and offers property and value-added services. Founded in 1986, it is headquartered in Shanghai, China.

Price · split & dividend adjusted
News & notes moving 600851.CG
China
600851.CG3

Haixin Shares' largest shareholder Ningrui Investment plans public solicitation to transfer part of its stake, possibly leading to a change in the largest shareholder

Haixin Shares announced on October 11 that its largest shareholder, Hunan Ningrui Investment Partnership, and its concert party, Hunan Caixin Economic Investment Co., Ltd., together hold 14.98% of the company's equity. Ningrui Investment plans to transfer part of the company's shares through public solicitation of transferees. This matter may lead to a change in the company's largest shareholder.
600851.CG · Capital · Neutral Largest shareholder Ningrui Investment plans a public solicitation to transfer part of its stake, possibly changing the largest shareholder.
Hunan Ningrui Investment Partnership · Capital · Neutral Ningrui Investment is the largest shareholder planning to transfer part of its Haixin Shares stake via public solicitation.
Hunan Caixin Economic Investment · Capital · Neutral Caixin Economic Investment is a concert party of Ningrui Investment, which plans the stake transfer.
Read original ↗
证券时报·12hRead more →
600851.CG▲4

Haixin Group's 2026 interim net profit reaches 129 million yuan, up 20.30% year on year

Haixin Group released its 2026 interim report, with net profit attributable to the parent company of 129 million yuan, up 20.30% from the same period last year, marking three consecutive years of growth. The company's total operating revenue was 312 million yuan, down 16.22% year on year. Net cash flow from operating activities was negative 58.1093 million yuan, down 169.64% from the same period last year. The company's latest asset-liability ratio was 16.24%, gross margin was 64.39%, and diluted earnings per share was 0.11 yuan.
600851.CG · Capital · Positive Net profit up 20.30% year on year, marking three consecutive years of growth.
Read original ↗
Jiemian·51dRead more →